Pfizer Lower Ahead of Earnings

Published on Monday, 30 January 2012 12:36 Written by Christian Paolinetti

New York, January 30th (TradersHuddle.com) - Shares of Pfizer, Inc. (NYSE:PFE) are trading lower by -0.40% ahead of its quarterly earnings release. Pfizer, the pharmaceutical company maker of Viagra and Lipitor is expected to release its quarterly results on January 31^st.

Wall Street Analysts consensus calls for a profit of $0.47 a share on $16.61 billion revenue.

Pfizer estimates have a range of $0.07 a share. The high estimate calls for profit of $0.5 a share and the low estimate is calling for a profit of $0.43 a share, a year ago for the quarter the company reported $0.47 a share.

Pfizer Inc. (NYSE:PFE), the global pharmaceutical company that develops, manufactures, and markets medicines for humans and animals. The Company's products include prescription and non-prescription pharmaceuticals, and animal health products such as anti-infective medicines and vaccines. Some of Pfizer blockbuster drugs are Celebrex for arthritis pain, and inflammation and acute pain, Viagra for erectile dysfunction, and Lipitor for elevated cholesterol levels in the blood. The company was founded in 1849 and is headquartered in New York, NY.

Other companies on the watch on this earnings event are Merck & Co. Inc. NYSE:MRK and Bristol-Myers Squibb Company NYSE:BMY.